Literature DB >> 17955185

Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function.

Yukiko Metsugi1, Yoshihiro Miyaji, Ken-ichi Ogawara, Kazutaka Higaki, Toshikiro Kimura.   

Abstract

PURPOSE: Mechanism for double-peak occurrence in plasma concentration profile after oral administration of drugs is controversial, although irregular gastric emptying would be an important factor. The objective of this study was to assess the effect of gastric emptying and a weight function, i.e. pharmacokinetics after reaching the systemic circulation, on the double-peak appearance in plasma concentration profiles.
MATERIALS AND METHODS: Alprazolam, which generates irregular gastric emptying, was orally co-administered with theophylline to rats, and the plasma concentration profiles or absorption rates were compared between the two drugs. Both drugs are highly absorbable, but alprazolam is rapidly eliminated from plasma, while the elimination of theophylline is very slow.
RESULTS: Oral administration of alprazolam generated the irregular gastric emptying profiles, resulting in multiple peaks in the absorption rate profiles of both drugs. The double peaks in the absorption rate profiles led to the double peaks in plasma concentration profiles for alprazolam, but not necessarily for theophylline. Simulation study clearly indicated that the slower elimination from plasma made the first peak less recognizable.
CONCLUSIONS: The irregular gastric emptying could be a main reason for the double peaks in plasma concentration profiles. However, the frequency of double-peak occurrence depends on the weight function, particularly the elimination rate, of each drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955185     DOI: 10.1007/s11095-007-9469-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  38 in total

1.  Absorption behavior of orally administered drugs in rats treated with propantheline.

Authors:  S Haruta; N Iwasaki; K Ogawara; K Higaki; T Kimura
Journal:  J Pharm Sci       Date:  1998-09       Impact factor: 3.534

2.  Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans.

Authors:  C Feinle; D Grundy; B Otto; M Fried
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-05       Impact factor: 3.619

3.  Intestinal absorption of a beta-adrenergic blocking agent nadolol. III. Nuclear magnetic resonance spectroscopic study on nadolol-sodium cholate micellar complex and intestinal absorption of nadolol derivatives in rats.

Authors:  T Yamaguchi; T Oida; C Ikeda; Y Sekine
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-10       Impact factor: 1.645

4.  Kinetics of acetaminophen absorption and gastric emptying in man.

Authors:  J A Clements; R C Heading; W S Nimmo; L F Prescott
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

5.  Kinetics and absolute bioavailability of atenolol.

Authors:  W D Mason; N Winer; G Kochak; I Cohen; R Bell
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

6.  Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs.

Authors:  V Mummaneni; G L Amidon; J B Dressman
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

7.  Regional gastrointestinal absorption of the beta-blocker pafenolol in the rat and intestinal transit rate determined by movement of 14C-polyethylene glycol (PEG) 4000.

Authors:  H Lennernäs; C G Regårdh
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

8.  Penicillamine kinetics in normal subjects.

Authors:  R F Bergstrom; D R Kay; T M Harkcom; J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1981-09       Impact factor: 6.875

9.  Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.

Authors:  Su Yeon Yu; Hye Chin Chung; Eun Jung Kim; So Hee Kim; Inchull Lee; Sang Geon Kim; Myung Gull Lee
Journal:  J Pharm Pharmacol       Date:  2002-12       Impact factor: 3.765

10.  Absorption of flurbiprofen in the fed and fasted states.

Authors:  J B Dressman; R R Berardi; G H Elta; T M Gray; P A Montgomery; H S Lau; K L Pelekoudas; G J Szpunar; J G Wagner
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

View more
  10 in total

Review 1.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

2.  Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.

Authors:  Wai Johnn Sam; Orsolya Roza; Yuen Yi Hon; Raul M Alfaro; Karim A Calis; James C Reynolds; Jack A Yanovski
Journal:  J Clin Pharmacol       Date:  2016-08-23       Impact factor: 3.126

3.  Pharmacokinetic Comparison of Nine Bioactive Compounds of Guanxinshutong Capsule in Normal and Acute Myocardial Infarction Rats.

Authors:  Yuting Yang; Jiehong Yang; Wei Fu; Peng Zhou; Yu He; Mingsun Fang; Haitong Wan; Huifen Zhou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-06-25       Impact factor: 2.569

4.  A trial for the design and optimization of pH-sensitive microparticles for intestinal delivery of cinnarizine.

Authors:  Hussein O Ammar; Mahmoud Ghorab; Rabab Kamel; Alaa H Salama
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

5.  An effective UFLC-MS/MS method used to study pharmacokinetics of major constituents of Fukeqianjin formula in rat plasma.

Authors:  Kanghua Wang; Lu Liu; Yanfang Yang; Xiaoyan Liu; Lei Zhang; Wei Xu; Yingtao Zhang; Xiuwei Yang; Peng Zhang; Kaifeng Peng; Yun Gong; Nifu Liu
Journal:  Chin Med       Date:  2020-07-25       Impact factor: 5.455

6.  Pharmacokinetics Studies of 12 Alkaloids in Rat Plasma after Oral Administration of Zuojin and Fan-Zuojin Formulas.

Authors:  Ping Qian; You-Bo Zhang; Yan-Fang Yang; Wei Xu; Xiu-Wei Yang
Journal:  Molecules       Date:  2017-01-30       Impact factor: 4.411

7.  Assessment of a developed HPLC-MS/MS approach for determining plasma eupatorin in rats and its application in pharmacokinetics analysis.

Authors:  Rui Feng; Luya Li; Xiaowei Zhang; Yuqian Zhang; Yuting Chen; Xue Feng; Lantong Zhang; Guohua Zhang
Journal:  RSC Adv       Date:  2020-08-28       Impact factor: 4.036

8.  Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.

Authors:  Tian-Tian Tang; Xiong-Bin Hu; De-Hua Liao; Xin-Yi Liu; Da-Xiong Xiang
Journal:  Int J Nanomedicine       Date:  2013-11-19

9.  Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats.

Authors:  Tae Hwan Kim; Subindra Kazi Thapa; Da Young Lee; Seung Eun Chung; Jun Young Lim; Hyeon Myeong Jeong; Chang Ho Song; Youn-Woong Choi; Sang-Min Cho; Kyu-Yeol Nam; Won-Ho Kang; Soyoung Shin; Beom Soo Shin
Journal:  Pharmaceutics       Date:  2018-09-06       Impact factor: 6.321

10.  Physiologically Based Pharmacokinetic Modelling of Cabozantinib to Simulate Enterohepatic Recirculation, Drug-Drug Interaction with Rifampin and Liver Impairment.

Authors:  Bettina Gerner; Oliver Scherf-Clavel
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.